BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210830
DTEND;VALUE=DATE:20210903
DTSTAMP:20260515T205453
CREATED:20210322T113138Z
LAST-MODIFIED:20210322T113138Z
UID:29478-1630281600-1630627199@www.pharmajournalist.com
SUMMARY:6th CAR-TCR Summit
DESCRIPTION:The CAR-TCR industry has started 2021 with a bang! With the 4th CAR-T gaining long-awaited approval\, Bristol-Myers Squibb have stepped onto the commercial stage\, and the CAR-TCR field continues to boom with excitement as the competition heats up. \nThe current approved therapies have encountered significant difficulties in the commercial market. Cell Therapies come with a high price tag\, little long-term efficacy data\, and expensive manufacturing processes. Now\, your community must gather to: \n\nAchieve consistency in manufacturing\, focusing on automation\, allogeneic platforms\, scalability\, and engineering techniques\nDemonstrate durable response with enhanced construct design\,optimized trial design\, and long-term follow-up data\nOvercome solid tumor hurdles with combination strategy\, specialized clinical delivery\, and next-generation engineering strategies\n\nThese challenges require ground-breaking work\, from discovery through to commercialization. Join the 6th CAR-TCR Summit to learn from the key opinion leaders\, and international innovators of the CAR-TCR community\, this September. \nSee more – https://ter.li/ofwzn3
URL:https://www.pharmajournalist.com/event/6th-car-tcr-summit/
LOCATION:Digital | EDT
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR